Bonzun AB
Bonzun AB (publ) operates as a healthcare company that provides Internet-based health services in Sweden. The company offers solutions for stress-related disorders. It also provides support services to the therapists who work with stress, cardiovascular disease, anxiety, relationship problems, etc. The company was formerly known as Papilly AB (publ) and changed its name to Bonzun AB (publ). Bonzu… Read more
Market Cap & Net Worth: Bonzun AB (BONZUN)
Bonzun AB (ST:BONZUN) has a market capitalization of $29.12 Million (Skr326.69 Million) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #45272 globally and #669 in its home market, demonstrating a 5.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bonzun AB's stock price Skr9.50 by its total outstanding shares 34388100 (34.39 Million).
Bonzun AB Market Cap History: 2015 to 2025
Bonzun AB's market capitalization history from 2015 to 2025. Data shows change from $268.89 Million to $29.12 Million (-21.01% CAGR).
Index Memberships
Bonzun AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$4.63 Billion | 0.00% | #239 of 281 |
Weight: Bonzun AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bonzun AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bonzun AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Bonzun AB's market cap is 0.03 times its annual revenue
0.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
Bonzun AB's market cap is 0.01 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $268.89 Million | $61.36K | -$7.32 Million | 4382.11x | N/A |
| 2016 | $162.20 Million | $16.82K | -$10.43 Million | 9644.83x | N/A |
| 2017 | $120.27 Million | $905.75K | -$20.57 Million | 132.79x | N/A |
| 2018 | $12.81 Million | $1.09 Million | -$11.57 Million | 11.78x | N/A |
| 2019 | $10.22 Million | $1.32 Million | -$13.37 Million | 7.75x | N/A |
| 2020 | $9.25 Million | $554.88K | -$10.37 Million | 16.67x | N/A |
| 2021 | $2.71 Million | $359.48K | -$10.29 Million | 7.55x | N/A |
| 2022 | $823.67K | $1.09 Million | -$43.38 Million | 0.76x | N/A |
| 2023 | $95.03K | $2.74 Million | $13.88 Million | 0.03x | 0.01x |
Competitor Companies of BONZUN by Market Capitalization
Companies near Bonzun AB in the global market cap rankings as of March 18, 2026.
Key companies related to Bonzun AB by market ranking:
- LabGenomics Co. Ltd (KQ:084650): Ranked #24330 globally with a market cap of $25.72 Million USD ( ₩37.66 Billion KRW).
- Las Condes (SN:LASCONDES): Ranked #40485 globally with a market cap of $126.42K USD ( CL$127.04 Million CLP).
- Shifa International Hospitals Ltd (KAR:SHFA): Ranked #44147 globally with a market cap of $16.57K USD ( PKRs4.62 Million PKR).
- Cannassure Therapeutics Ltd (TA:CSURE): Ranked #48747 globally with a market cap of $583.00 USD ( ILA217.46K ILA).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #24330 | LabGenomics Co. Ltd | KQ:084650 | $25.72 Million | ₩1386.00 |
| #40485 | Las Condes | SN:LASCONDES | $126.42K | CL$13650.00 |
| #44147 | Shifa International Hospitals Ltd | KAR:SHFA | $16.57K | PKRs474.18 |
| #48747 | Cannassure Therapeutics Ltd | TA:CSURE | $583.00 | ILA735.00 |
Bonzun AB Historical Marketcap From 2015 to 2025
Between 2015 and today, Bonzun AB's market cap moved from $268.89 Million to $ 29.12 Million, with a yearly change of -21.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | Skr29.12 Million | +121694.87% |
| 2024 | Skr23.91K | -74.84% |
| 2023 | Skr95.03K | -88.46% |
| 2022 | Skr823.67K | -69.66% |
| 2021 | Skr2.71 Million | -70.65% |
| 2020 | Skr9.25 Million | -9.49% |
| 2019 | Skr10.22 Million | -20.21% |
| 2018 | Skr12.81 Million | -89.35% |
| 2017 | Skr120.27 Million | -25.85% |
| 2016 | Skr162.20 Million | -39.68% |
| 2015 | Skr268.89 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bonzun AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.12 Million USD |
| MoneyControl | $29.12 Million USD |
| MarketWatch | $29.12 Million USD |
| marketcap.company | $29.12 Million USD |
| Reuters | $29.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.